GlobeNewswire - Stock Market News

Visionstate announces Exchange acceptance and closing of previously announced private placement

Sat, 27 Feb 2021 01:54 GMT

EDMONTON, Alberta, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Visionstate Corp. (TSX-V: VIS) (“Visionstate”) is pleased to announce the final acceptance from the TSX Venture Exchange and closing of its over-subscribed, non-brokered private placement financing ("Private Placement") for gross proceeds of $1,505,000 or 30,100,000 units ("Units") at a price of $0.05 per Unit.

West Mining Corp. Closes Over-Subscribed Financing for $6,600,000

Sat, 27 Feb 2021 00:12 GMT

Not for distribution to United States newswire services or for dissemination in the United States

ThreeD Capital Inc. Acquires Securities of Windfall Geotek Inc.

Sat, 27 Feb 2021 00:06 GMT

TORONTO, Feb. 26, 2021 (GLOBE NEWSWIRE) -- ThreeD Capital Inc. (“ThreeD” or the “Company”) (CSE:IDK / OTCQB:IDKFF) a Canadian based venture capital firm that invests in disruptive companies and promising junior resources companies, is pleased to announce that it has acquired ownership and control of an aggregate of 8,889,500 common shares (the “Subject Shares”) and 1,000,000 common share purchase warrants (the “Subject Warrants” and together with the Subject Shares, the “Subject Units”) of Windfall Geotek Inc. (“Windfall”) through a series of transactions ending on February 19, 2021. The Subject Shares represented approximately 10.0% of all issued and outstanding common shares of Windfall as of February 26, 2021 immediately following the transaction described above (or approximately 11.0% on a partially diluted basis, assuming exercise of the Subject Warrants only).

Affinor Growers Announces Closing of Non-Brokered Unit Private Placement

Fri, 26 Feb 2021 22:24 GMT

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES

Fairfax India Completes US$500 Million Senior Notes Offering

Fri, 26 Feb 2021 22:19 GMT

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES

Early Warning Release

Fri, 26 Feb 2021 22:18 GMT

All amounts in Canadian dollars unless otherwise stated.

Fairfax Announces Early Redemption of Senior Notes Due October 14, 2022 and March 22, 2023

Fri, 26 Feb 2021 22:02 GMT

TORONTO, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Fairfax Financial Holdings Limited (“Fairfax”) (TSX: FFH and FFH.U) announces that, on March 28, 2021, it is redeeming all of its outstanding 5.84% senior notes due October 14, 2022 (the “2022 Notes”) at a redemption price of 106.999% of the principal amount of the 2022 Notes plus accrued and unpaid interest, if any. There is C$446 million principal amount of 2022 Notes currently outstanding.

Eguana Announces Date for First Quarter 2021 Financial Results and Conference Call

Fri, 26 Feb 2021 22:00 GMT

CALGARY, Alberta, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Eguana Technologies Inc. (“Eguana” or the “Company”) (TSX.V: EGT) (OTCQB: EGTYF) will post its financial results for the first quarter of 2021 after close of market on March 1, 2021. Eguana management will host a conference call on Monday March 1st, at 5:00 p.m. eastern time (EST) to discuss the quarter results, provide a business update, and hold a live question and answer period. Registration in advance is required.

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule?5635(c)(4)

Fri, 26 Feb 2021 21:32 GMT

SOUTH SAN FRANCISCO, Calif., Feb. 26, 2021 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on February 26, 2021 it granted stock options to purchase an aggregate of 9,000 shares of common stock to Wing Keung Chiu, a new employee whose employment commenced in February 2021 as a material inducement to his employment. The grant was previously approved by the Compensation and Talent Committee of Cytokinetics’ Board of Directors under the company’s Amended and Restated 2004 Equity Incentive Plan.

Malvern Bancorp, Inc. Announces Receipt of Nasdaq Letter and Rescheduling of Its Annual Meeting of Shareholders

Fri, 26 Feb 2021 21:21 GMT

PAOLI, Pa., Feb. 26, 2021 (GLOBE NEWSWIRE) -- Malvern Bancorp, Inc. (NASDAQ: MLVF)?(the “Company”), the parent company of Malvern Bank, National Association, today announced that it received a notification letter on February 23, 2021 from The Nasdaq Stock Market (“Nasdaq”). The notification letter stated that because the Company has not yet filed its Form 10-Q for the first fiscal quarter end December 31, 2020 (the “Form 10-Q”), and therefore remains delinquent in filing its Form 10-Q, the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely filing of periodic reports with the Securities and Exchange Commission (the “SEC”).

Grey Cloak Tech Inc. Announces Official Name Change to Healthy Extracts Inc and Ticker Symbol HYEX

Fri, 26 Feb 2021 21:13 GMT

LAS VEGAS, Feb. 26, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Grey Cloak Tech Inc. (OTCQB: GRCK) is pleased to announce they will officially change their name to Healthy Extracts Inc in conjunction with its new symbol OTCQB: HYEX on March 1^st, 2021. The company is engaged in proprietary development of natural plant-based formulations as well as sales and distribution of cardiovascular and neuro products.

Xtant Medical Comments on Trading Activity of its Stock

Fri, 26 Feb 2021 21:05 GMT

BELGRADE, Mont., Feb. 26, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT, the “Company”), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced that it is not aware of any material, undisclosed corporate developments or material change in its business or affairs that has not been publicly disclosed that would account for the recent increase in the market price or trading volume of its shares.

enCore Energy Corp. Announces Option Grants to Officers

Fri, 26 Feb 2021 20:45 GMT

VANCOUVER, British Columbia, Feb. 26, 2021 (GLOBE NEWSWIRE) -- enCore Energy Corp. (TSXV: EU; OTCQX:ENCUF) (the “Company”) announces that it has granted incentive stock options (the “Options”) to certain of its officers and consultants, to purchase an aggregate of up to 435,000 common shares in the capital of the Company at a price of $ 1.08 per share for a five year period, in accordance with its Stock Option Plan. Vesting will occur over a period of eighteen months, with an initial 25% of the Options vesting immediately upon grant, followed by an additional 25% of the Options every six months thereafter until fully vested.

DIAGNOS Announces Exercise of Stock Warrants and Provides a Cash Update

Fri, 26 Feb 2021 19:33 GMT

BROSSARD, Quebec, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX?Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces the exercise of 5,076,922 stock warrants within the past five months. The cash position of the Corporation as of today is $1,433,000.

DIAGNOS annonce l’exercice de bons de souscription et une mise à jour sur son encaisse

Fri, 26 Feb 2021 19:33 GMT

BROSSARD, Québec, 26 févr. 2021 (GLOBE NEWSWIRE) -- Diagnos inc. (??DIAGNOS??, la ??Société?? ou ??nous??) (Bourse de croissance TSX?: ADK) (OTCQB?: DGNOF), un leader dans le dépistage précoce de problèmes graves de santé grace à sa technologie d’intelligence artificielle (IA) FLAIRE, annonce qu’au cours des cinq derniers mois, 5?076?922 bons de souscriptions en actions ordinaires ont été exercés. L’encaisse, en date d’aujourd’hui, s’élève à 1?433?000?$.

BriaCell Announces Closing of US$25 Million Public Offering

Fri, 26 Feb 2021 19:24 GMT

BERKELEY, Calif. and VANCOUVER, British Columbia, Feb. 26, 2021 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (TSX-V:BCT) (NASDAQ: BCTX, BCTXW) (“BriaCell” or the “Company”), a clinical-stage biotechnology company specializing in targeted immunotherapies for advanced breast cancer, today closed its previously announced underwritten public offering in the United States. The Company offered 4,852,353 common units at a public offering price of US$4.25 per unit, consisting of one share of common stock and one warrant to purchase one share of common stock (“Warrant”), and 1,030,000 pre-funded units at a public offering price of US$4.24 per unit, consisting of one pre-funded common stock purchase warrant (“Pre-Funded Warrant”) and one Warrant. The Pre-Funded Warrants?are exercisable at any time after the date of issuance at an exercise price of US$0.01?per common share.? The Warrants have a per share exercise price of US$5.3125, can be exercised immediately, and expire five years from the date of issuance.

Westhaven Files Technical Report

Fri, 26 Feb 2021 18:42 GMT

VANCOUVER, British Columbia, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Westhaven Gold Corp. (TSX-V:WHN) reports that it has filed a technical report in respect of its Spences Bridges Group of Properties (the “SBG Properties”), including the Shovelnose property, dated February 7, 2021 entitled “National Instrument 43-101 Technical Report on the Spences Bridge Group of Properties (SBG Group), Nicola and Kamloops Mining Divisions, British Columbia.” (the “Technical Report”) as prepared by Bruce L. Laird P.Geo. which contains exploration and drilling information about the SBG Properties. The Company clarifies that SBG Properties are early stage properties and there are no resource estimates on any of the SBG Properties.

International Petroleum Corporation Announces Updated Share Capital

Fri, 26 Feb 2021 16:30 GMT

VANCOUVER, British Columbia, Feb. 26, 2021 (GLOBE NEWSWIRE) -- International Petroleum Corporation (IPC or the Corporation) (TSX, Nasdaq Stockholm: IPCO) reports the following, in accordance with the Swedish Financial Instruments Trading Act:

Adial Receives $1.425 Million in Net Proceeds from Exercise of Warrants

Fri, 26 Feb 2021 16:20 GMT

CHARLOTTESVILLE, Va., Feb. 26, 2021 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of treatments for addictions, today announced the exercise of 712,500 warrants from its June 2020 financing for net proceeds to the company of $1,425,000.

Field Trip Health Announces Upsize to Previously Announced Bought Deal Public Offering

Fri, 26 Feb 2021 15:17 GMT

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.